Page last updated: 2024-09-02

ecteinascidin 743 and temozolomide

ecteinascidin 743 has been researched along with temozolomide in 5 studies

Compound Research Comparison

Studies
(ecteinascidin 743)
Trials
(ecteinascidin 743)
Recent Studies (post-2010)
(ecteinascidin 743)
Studies
(temozolomide)
Trials
(temozolomide)
Recent Studies (post-2010) (temozolomide)
6601024046,0148264,331

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (40.00)29.6817
2010's2 (40.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Lombardo, F; Obach, RS; Waters, NJ1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Patel, SR1
Bernasconi, S; Caccuri, AM; Capozzi, O; Chiorino, G; Clivio, L; D'Incalci, M; Damia, G; Di Giandomenico, S; Erba, E; Fossati, A; Fuso Nerini, I; Ganzinelli, M; Grosso, F; Mantovani, R; Marangon, E; Marchini, S; Margison, GP; Pastore, A; Rocchi, M; Romano, M; Sala, F; Tercero, JC; Uboldi, S; Watson, AJ1
Coussens, NP; Dexheimer, TS; Doroshow, JH; Morris, J; Silvers, T; Teicher, BA; Wright, J1

Reviews

1 review(s) available for ecteinascidin 743 and temozolomide

ArticleYear
Developing therapeutic pharmaceuticals for the treatment of soft-tissue sarcomas.
    Expert opinion on investigational drugs, 2002, Volume: 11, Issue:12

    Topics: Antineoplastic Agents; Benzamides; Camptothecin; Dacarbazine; Deoxycytidine; Dioxoles; Gemcitabine; Humans; Imatinib Mesylate; Irinotecan; Isoquinolines; Piperazines; Pyrimidines; Sarcoma; Temozolomide; Tetrahydroisoquinolines; Trabectedin

2002

Other Studies

4 other study(ies) available for ecteinascidin 743 and temozolomide

ArticleYear
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Characterization of a new trabectedin-resistant myxoid liposarcoma cell line that shows collateral sensitivity to methylating agents.
    International journal of cancer, 2012, Jul-01, Volume: 131, Issue:1

    Topics: Antineoplastic Agents, Alkylating; Apoptosis; C-Reactive Protein; CCAAT-Enhancer-Binding Protein-alpha; CCAAT-Enhancer-Binding Protein-beta; Cell Line, Tumor; Dacarbazine; Dioxoles; DNA Methylation; DNA Modification Methylases; DNA Repair; DNA Repair Enzymes; Drug Resistance, Neoplasm; Fibronectins; Humans; Liposarcoma, Myxoid; Oncogene Proteins, Fusion; Promoter Regions, Genetic; RNA-Binding Protein FUS; Serum Amyloid P-Component; Signal Transduction; Temozolomide; Tetrahydroisoquinolines; Trabectedin; Transcription Factor CHOP; Tumor Suppressor Proteins; Ultraviolet Rays

2012
Multicellular Complex Tumor Spheroid Response to DNA Repair Inhibitors in Combination with DNA-damaging Drugs.
    Cancer research communications, 2023, Volume: 3, Issue:8

    Topics: Ataxia Telangiectasia; DNA; DNA Repair; DNA-Activated Protein Kinase; Endothelial Cells; Humans; Neoplasms; Spheroids, Cellular; Temozolomide; Topotecan; Trabectedin

2023